Literature DB >> 16326260

Evaluation and management of the patient who has cocaine-associated chest pain.

Judd E Hollander1, Timothy D Henry.   

Abstract

Patients who have chest pain following the use of cocaine have become more common in emergency departments throughout the United States,with approximately 6% of these patients sustaining an acute MI. The authors have described the rationale for recommending aspirin, benzodiaze-pines, and nitroglycerin as first-line treatments and calcium-channel blockade or phentolamine as possible second-line therapies and have summarized the controversies surrounding the use of fibrinolytic agents. Admission for observation is one reasonable approach to the management of the low-risk cohort. Evaluation for underlying coronary artery disease is reasonable, particularly in patients who have acute MI. Patients who do not have infarction can undergo evaluation for possible coronary artery disease on an outpatient basis. Routine interventions for secondary prophylaxis as well as cocaine rehabilitation should be used in this patient population, because the long-term prognosis seems somewhat dependent upon the ability of the patient to discontinue cocaine use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16326260     DOI: 10.1016/j.ccl.2005.09.003

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  12 in total

1.  Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Authors:  Gregory T Collins; Remy L Brim; Kathleen R Noon; Diwahar Narasimhan; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-04-19       Impact factor: 4.030

2.  Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Authors:  Gregory T Collins; Kathy A Carey; Diwahar Narasimhan; Joseph Nichols; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  Targeted disruption of K(ATP) channels aggravates cardiac toxicity in cocaine abuse.

Authors:  Santiago Reyes; Garvan C Kane; Leonid V Zingman; Satsuki Yamada; Andre Terzic
Journal:  Clin Transl Sci       Date:  2009-10       Impact factor: 4.689

Review 4.  Cardiovascular hypertensive emergencies.

Authors:  D P Papadopoulos; E A Sanidas; N A Viniou; V Gennimata; V Chantziara; I Barbetseas; T K Makris
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

5.  A prehospital acute coronary syndrome in a cocaine user: an unstable clinical situation.

Authors:  Nicolas Franchitto; Claudine Cabot; Nicolas Dumonteil; Vincent Bounes; Atul Pathak; Daniel Rougé
Journal:  J Med Toxicol       Date:  2012-03

6.  One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain.

Authors:  Rebecca Cunningham; Maureen A Walton; Jim Edward Weber; Samantha O'Broin; Shanti P Tripathi; Ronald F Maio; Brenda M Booth
Journal:  Ann Emerg Med       Date:  2008-09-27       Impact factor: 5.721

7.  Is cocaine use recognised as a risk factor for acute coronary syndrome by doctors in the UK?

Authors:  David M Wood; Duncan Hill; Awini Gunasekera; Shaun L Greene; Alison L Jones; Paul I Dargan
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

Review 8.  Cocaine and Cardiotoxicity: A Literature Review.

Authors:  Joseph V Pergolizzi; Peter Magnusson; Jo Ann K LeQuang; Frank Breve; Giustino Varrassi
Journal:  Cureus       Date:  2021-04-20

9.  Outcomes of Patients With Cocaine Induced Chest Pain in An Inner City Hospital.

Authors:  Moustapha Atoui; Nadia Fida; Suresh Kumar Nayudu; Mariela Glandt; Sridhar Chilimuri
Journal:  Cardiol Res       Date:  2011-11-20

10.  Cocaine and thrombosis: a narrative systematic review of clinical and in-vivo studies.

Authors:  Nat Mj Wright; Matthew Martin; Tom Goff; John Morgan; Rebecca Elworthy; Shariffe Ghoneim
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.